Topic
Pathology
23 Podcasts • 8 Cases • 2 Courses on BackTable
Hear how experienced clinicians in Pathology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 67 • 18 Jun 2026
Bladder Cancer Risk Stratification: Best Practices
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate and high-risk patients? In this episode of BackTable, Dr. Bogdana Schmidt interviews urologists Dr. Kristen Scarpato and Dr. Sunil Patel to explore the complexities of diagnosis and risk assessment in non–muscle invasive bladder cancer (NMIBC). They discuss the real-world challenges of pathology interpretation, risk-group assignment, evolving diagnostic tools, and the impact these factors have on treatment decisions and patient outcomes.
This podcast is supported by an educational grant from Johnson & Johnson.
More on Pathology
Loading recent podcasts…
Tumor Board # 67
Jun 18, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
30+ listens
Tumor Board # 52
Mar 24, 2026
with Dr. Sara Nunnery, Dr. Kate Baker
Antibody-drug conjugates (ADCs) are expanding treatment options in breast cancer, but their use requires careful...
170+ listens
Tumor Board # 43
Jan 13, 2026
with Dr. Jun Gong, Dr. Jonathan Mizrahi
Get caught up on the cutting edge colorectal cancer trial data from ESMO 2025 with this 30-minute BackTable Tumor Board...
270+ listens
Tumor Board # 41
Dec 30, 2025
with Dr. Shubham Pant, Dr. Jonathan Mizrahi
Metastatic pancreatic cancer is no longer a ‘one size fits all’ diagnosis. In this episode of the BackTable Tumor Board...
380+ listens
Urology # 310
Jun 18, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
880+ listens
Tumor Board # 44
Jan 20, 2026
with Dr. Jonathan Mizrahi, Dr. Jun Gong
The FLOT regimen is the standard-of-care for upper gastroesophageal malignancies, but what if there were other drug...
140+ listens
Vascular & IR # 603
Jan 2, 2026
with Dr. Robert Suh, Dr. Alan Lee, Dr. Scott Oh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might simultaneous ablation and biopsy be the new standard for high-probability lung cancer cases where surgery...
1,300+ listens
Tumor Board # 39
Dec 9, 2025
with Dr. Robert Suh, Dr. Scott Oh, Dr. Alan Lee, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might simultaneous ablation and biopsy be the new standard for high-probability lung cancer cases where surgery...
370+ listens
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
VI Case
Nov 21, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Case
Jul 20, 2026
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
Urology Course
3 hours, 28 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.